Literature DB >> 10419485

Murine SHP-1 splice variants with altered Src homology 2 (SH2) domains. Implications for the SH2-mediated intramolecular regulation of SHP-1.

A Martin1, H W Tsui, M J Shulman, D Isenman, F W Tsui.   

Abstract

SHP-1 is a protein-tyrosine phosphatase with two Src homology 2 (SH2) domains. These SH2 domains determine which proteins SHP-1 associates with, but they also autoregulate the activity of the catalytic domain. In this report, we find that the murine SHP-1 transcript is processed to yield a series of alternatively spliced in-frame transcripts, the majority of which exclude exons encoding one or the other SH2 domain. We have examined the corresponding protein isoforms in several ways. First, our measurements of V(max) and K(m) under different conditions indicate that the SH2 variants have elevated activity because of lessened autoregulation. Second, to ascertain whether regulation by the SH2 domains reflects intra- or intermolecular effects, we analyzed the state of SHP-1 by high performance liquid chromatography and sucrose density gradient centrifugation. Our results showed that SHP-1 is a monomer and, thus, is regulated in an intramolecular manner. Third, our analyses detected shape differences between SHP-1 and the active splice variant protein deleted of the amino-terminal SH2 domain; i.e. SHP-1 was globular and resistant to proteolytic digestion, while the splice variant protein was "rod-shaped" and more susceptible to proteolytic digestion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419485     DOI: 10.1074/jbc.274.31.21725

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia.

Authors:  George P Christophi; Chad A Hudson; Ross Gruber; Christoforos P Christophi; Paul T Massa
Journal:  J Neurochem       Date:  2008-06-01       Impact factor: 5.372

2.  Dihydroxypentamethoxyflavone down-regulates constitutive and inducible signal transducers and activators of transcription-3 through the induction of tyrosine phosphatase SHP-1.

Authors:  Kanokkarn Phromnoi; Sahdeo Prasad; Subash C Gupta; Ramaswamy Kannappan; Simone Reuter; Pornngarm Limtrakul; Bharat B Aggarwal
Journal:  Mol Pharmacol       Date:  2011-08-04       Impact factor: 4.436

Review 3.  Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1.

Authors:  Florence W L Tsui; Alberto Martin; John Wang; Hing Wo Tsui
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients.

Authors:  George P Christophi; Chad A Hudson; Ross C Gruber; Christoforos P Christophi; Cornelia Mihai; Luis J Mejico; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2008-01-21       Impact factor: 5.662

5.  Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1.

Authors:  George P Christophi; Michael Panos; Chad A Hudson; Chriso Tsikkou; Cornelia Mihai; Luis J Mejico; Burk Jubelt; Paul T Massa
Journal:  Clin Immunol       Date:  2009-06-25       Impact factor: 3.969

6.  Genome-wide review of transcriptional complexity in mouse protein kinases and phosphatases.

Authors:  Alistair R R Forrest; Darrin F Taylor; Mark L Crowe; Alistair M Chalk; Nic J Waddell; Gabriel Kolle; Geoffrey J Faulkner; Rimantas Kodzius; Shintaro Katayama; Christine Wells; Chikatoshi Kai; Jun Kawai; Piero Carninci; Yoshihide Hayashizaki; Sean M Grimmond
Journal:  Genome Biol       Date:  2006-01-26       Impact factor: 13.583

7.  Regulation of autoimmune arthritis by the SHP-1 tyrosine phosphatase.

Authors:  Adrienn Markovics; Daniel M Toth; Tibor T Glant; Katalin Mikecz
Journal:  Arthritis Res Ther       Date:  2020-06-26       Impact factor: 5.156

8.  Regulation of hERG and hEAG channels by Src and by SHP-1 tyrosine phosphatase via an ITIM region in the cyclic nucleotide binding domain.

Authors:  Lyanne C Schlichter; Jiahua Jiang; John Wang; Evan W Newell; Florence W L Tsui; Doris Lam
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.